Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities-A Systematic-Review

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Wilbur, Kerry ^a   Hazi, Huda ^a   El Bedawi, Aya ^a  

^a Qatar University ^*  (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONYLUREA; THIAZIDE DIURETIC AGENT; WARFARIN;

ANEMIA; ARTICLE; BRADYCARDIA; DRUG INDUCED DISEASE; DRUG MONITORING; DRUG USE; EMERGENCY WARD; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPOGLYCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; INCIDENCE; KIDNEY FAILURE; MELENA; NEUTROPENIA; PREVALENCE; SYSTEMATIC REVIEW; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; PATHOPHYSIOLOGY;

DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HOSPITALIZATION; HUMANS;

EID: 84879539936     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066803     Document Type: Article

References (65)

1. Hepler CD, Strand LM, (1990) Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47: 533-43.
2. Easton KL, Parsons BJ, Brien J, (2004) Frequency and characteristics of hospital admissions associated with drug-related problems in pediatrics. Br J Clin Pharmacol 57: 611-5.
3. Samoy LJ, Zed PJ, Wilbur K, Balen RM, Abu-Laban RB, et al. (2006) Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy 26: 1578-86.
4. Zed PJ, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, et al. (2008) Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. Can Med Assoc J 178: 1563-69.
5. Singh H, Kumar BN, Sinha T, Dulhani N, (2011) The incidence and nature of drug-related hospital admission: a 6-month observational study in a tertiary health care hospital. J Pharmacol Pharmacother 2: 17-20.
6. Howard RL, Avery AI, Slavenburg S, Royal S, Pipe G, et al. (2006) Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 6: 136-147.
7. Leendertse AJ, Egherts ACG, Stoker LJ, van den Bernt PM, (2008) HARM Study Group (2008) Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 168: 1890-96.
8. Atiqi R, van Bommel E, Cleophas TJ, Zwinderman AH, (2010) Prevalence of iatrogenic admissions to the Departments of Medicine/Cardiology/Pulmonology in a 1,250 bed general hospital. Int J Clin Pharm Ther 48: 517-24.
9. Warle-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PM, De Smet PA, et al. (2012) Targeting outpatient drug safety recommendations of the Dutch HARM-Wrestling Task Force. Drug Safety 3: 245-59.
10. Steinman MA, Handler SM, Gurwitz JH, Schiff GD, Covinsky KE, (2011) Beyond the prescription: medication monitoring and adverse drug events in older adults. JAGS 59: 1513-20.
11. Leendertse AJ, de Koning FHP, Goudswaard AN, Jonkhoff AR, van den Bogert SC, et al. (2011) Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomized, controlled, multi-centre PHARM-study. BMC Health Serv Res 11: 4.
12. Morrato EH, Newcomer JW, Allen RR, Valuck RJ, (2008) Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, populations-based study of Medicaid claims data. J Clin Psychiatr 69: 316-22.
13. Tija T, Field TS, Garber LD, Donovan JL, Kanaan AO, et al. (2010) Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting. Am J Manag Care 16: 489-96.
14. Tija J, Fischer SH, Raebel MA, Peterson D, Zhao Y, et al. (2011) Baseline and follow-up of laboratory monitoring of cardiovascular medications. Ann Pharmacother 45: 1077-84.
15. James K, Bellomo R, Poustie S, Story DA, McNicol PL, (2000) The epidemiology of major early adverse physiological events after surgery. Crit Care Resuscitation 2: 108-13.
16. STROBE Statement. Strengthening the reporting of observational studies in epidemiology. Strobe checklist for cohort, case-control, and cross-sectional studies. Available: URL: http://www.strobe-statement.org/index.php?id=available-checklists. Accessed 2011 Nov 28.
17. Smyth RMD, Gargon E, Kirkham, Cresswell L, Golder S, et al. (2012) Adverse drug reactions in children- a systematic review. PLoS ONE 7: e24062 doi:10.1371/journal.pone.0024061.
18. Foisy M, (2000) Hospitalization due to ADR and DI before and after HAART. Can J Infect Dis 11: 193-201.
19. Green CF, (2000) ADRS as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharmacol Ther 25: 355-61.
20. Chan M, Nicklason F, Vial JL, (2001) Adverse drug events ADEs as a cause of hospital admission in the elderly. Intern Med J 31: 199-205.
21. Hohl CM, Dankoff J, Coescone A, Afilalo M, (2001) Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 38: 666-71.
22. Wasserfallen JB, Livio F, Buclin T, Tillet L, Yersin B, et al. (2001) Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med 12: 442-7.
23. McDonnell PJ, Jacobs MR, (2002) Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 36: 1331-6.
24. Mjorndal T, Boman MD, Hagg S, Backstrom M, Wiholm BE, et al. (2002) Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 11: 65-72.
25. Howard RL, Avery AJ, Howard PD, Partridge M, (2003) Investigation into the reasons for preventable ADRS to a medical admissions unit: observational study. Qual Saf Health Care 12: 280-5.
26. Juntti-Patinen L, Kuitunen T, Pere P, (2006) Drug-related visits to a district hospital emergency room. Bas Clin Pharmacol Tox 28: 212-7.
27. von Euler M, Eliasson E, Ohlen G, Bergman U, (2006) Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf 15: 179-84.
28. Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, et al. (2007) Trends in hospital admissions for ADRs in England: analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol 7: 9.
29. Rivkin A, (2007) Admissions to medical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm 64: 1840-3.
30. Alexapoulou A, Dourakis SP, Mantzoukis D, Pitsariotis T, Kandyli A, et al. (2008) Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med 19: 505-10.
31. Franchesci M, (2008) Prevalence, clinical features and availability of ADRs as a cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Safety 31: 545-56.
32. Hopf Y, Watson M, Williams D, (2008) Adverse drug reaction related admissions to a hospital in Scotland. Pharm World Sci 30: 854-62.
33. Brvar M, Fokter N, Bunc M, Mozina M, (2009) The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department speciality. BMC Clin Pharmacol 9: 8 doi:10.1186/1472-6904-9-8.
34. Rogers S, Wilson D, Wan S, Griffin M, Rai G, et al. (2009) Medication-related admissions in older people: a cross-sectional observational study. Drugs Aging 26: 951-61.
35. Wawruch M, Zikavska M, Wsolova L, Kuzelova K, Kahayova K, et al. (2009) Adverse drug reactions related to hospital admissions in Slovak elderly patients. Arch Gerentol Geriatr 48: 186-90.
36. Davies EC, Green CF, Moltram DR, Rowe PH, Pimohamed M, (2010) Emergency re-admissions to hospital due to adverse drug reactions within 1 year of index admission. Br J Clin Pharmacol 70: 749-55.
37. Fokter N, (2010) Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments. Wien Klin Wochenschr 122: 81-8.
38. Hartholt KA, van der Velde N, Looman CW, Pannerman MJ, van Beeck EF, et al. (2010) Adverse drug reactions related hospital admissions in persons aged 60 years and over. The Netherlands 1981-2007: less rapid increase, different drugs. PLoS One 5: e13977.
39. Rodenburg EM, Stricker BH, Visser LE, (2010) Sex-related differences in hospital admissions attributed to adverse drug reaction in the Netherlands. Br J Clin Pharmacol 71: 95-104.
40. Somers A, Robays H, Vander Stichele R, van Maele G, Bogaert M, et al. (2010) Contribution of drug related problems to hospital admissions in elderly. J Nutr Health Aging 14: 476-82.
41. Gallagher RM, Bird KA, Mason JR, Peak M, Williamson PR, et al. (2011) Adverse drug reactions causing admission to a paediatric hospital: a pilot study. J Clin Pharm Ther 36: 194-99.
42. Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, et al. (2011) Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharm 67: 741-52.
43. Hofer-Dueckelmann C, Prinz E, Beindl W, Szymanski J, Fellhofer G, et al. (2011) ADRs associated with hospital admissions - elderly female patients are at higher risk. Int J Clin Pharmacol Ther 49: 577-86.
44. Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, et al. (2012) Prevalence of unplanned hospitalizations caused by ADRs in veterans. J Am Geriatri Soc 60: 34-41.
45. Miranda V, Fede A, Nobuo M, Ayres V, Giglio A, et al. (2011) Adverse drug reactions and drug interaction as causes of hospital admission in oncology. J Pain Symptom Manage 42: 342-53.
46. Noize P, Bagheri H, Durrieu G, Haramburu F, Moore N, et al. (2011) Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals. Pharmacoepidemiol Drug Saf 20: 747-53.
47. Varallo FR Capucho HC, Planeta CS, Mastroianni PdeC, (2011) Safety assessment of potentially inappropriate medications use in older people and the factors associated with hospital admission. J Pharm Pharmaceut Sci 14: 283-90.
48. Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, et al. (1990) Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 228: 83-90.
49. Shumock GT, Thornton JP, (1992) Focusing on the preventability of adverse drug reactions. Hosp Pharm 27: 538 Letter.
50. Gurwitz JH, Field TS, Harold LR, Rothschild J, Debellis K, et al. (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289: 1107-16.
51. Leendertse AJ, Visser D, Egberts ACG, van Den Bemt PM, (2010) The relationship between study characteristics and the prevalence of medication-related hospitalizations. A literature review and novel analysis. Drug Saf 33: 233-44.
52. Ajdukovic M, Crook M, Angley C, Stupans I, Soulsby N, et al. (2007) Pharmacist elicited medication histories in the Emergency Department: identifying patient groups at risk of medication misadventure. Pharm Pract 5: 162-8.
53. Hohl CM, Zed PJ, Brubacher JR, Abu-Laban RB, Loewen PS, et al. (2010) Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Ann Emerg Med 55: 493-502.
54. World Health Organization (1970) International drug monitoring-the role of the hospital. A WHO report. Drug Intell Clin Pharm 4: 101-11.
55. von Mil JW, Westlerlund LO, Hersberger KE, Schaefer MA, (2004) Drug-related problem classification systems. Ann Pharmacother 38: 859-67.
56. Raebel MA, Lyons EE, Chester EA, Bodily MA, Kelleher JA, et al. (2005) Improving laboratory monitoring at initiation of drug therapy in ambulatory care. Arch Intern Med 165: 2395-2401.
57. Tija J, Fisher S, Raebel MA, Peterson D, Zhao Y, et al. (2011) Baseline and follow-up of laboratory monitoring of cardiovascular medications. Ann Pharmacother 45: 1077-84.
58. Goldman RE, Soran CS, Hayward GL, Simon SR, (2010) Doctors' perceptions of laboratory monitoring in office practice. J Eval Clin Pract 16: 1136-41.
59. Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, et al. (2009) The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database of Syst Rev DOI:10.1002/14651858.CD001096.pub2.
60. Bhardwaja B, Carroll NM, Raebel MA, Chester EA, Korner EJ, et al. (2011) Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: the Drug Renal Alert Pharmacy (DRAP) Program. Pharmacotherapy 31: 346-56.
61. Smith DH, Feldstein AC, Perrin NA, Yang X, Rix MM, et al. (2009) Improving laboratory monitoring of medications: an economic analysis alongside a clinical trial. Am J Managed Care 15: 281-9.
62. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, et al. (1995) Systems analysis of adverse drug events. JAMA 274: 35-43.
63. Jones TA, Como JA, (2003) Assessment of medication errors that involved drug allergies at a university hospital. Pharmacotherapy 23: 855-60.
64. Bolesta S, Trombetta DP, Longyhore DS, (2011) Pharmacist instruction of physical assessment for pharmacy students. Am J Pharm Edu 75: Article 29.
65. Barry AR, McCarthy L, Nelson CL, Pearson GJ, (2012) An evaluation of teaching physical examination to pharmacists. Can Pharm J 145: 174-79.